Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Policy / Pricing

US pharma tariffs of up to 100% finalised by Trump

 April 3, 2026

Pharmaphorum

Trump signs his pharma tariffs executive order, which won’t affect most large pharma groups but could deal a hefty blow to smaller companies.

Policy / PricingRead full story

Post navigation

Trump Hits Drugmakers With 100% Tariff but Carve-outs Soften the Blow →
← BioNTech Starts Shuttering Singapore mRNA Manufacturing Site Amid Pipeline Pivot

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com